Join this panel if you like to learn about the prospects of management consulting as a career. This would be a great place to find answers for your curiosities about this career path and how you can prepare yourself for this journey.
This 75-minute event is planned by the Graduate Consulting Club (GCC) and Graduate Engineering Student Council (GESC) at UVA.
Zoom
https://virginia.zoom.us/j/4091517734
Calendar
Panelists
Brendan Boler, Ph.D., Management, UVA Darden School of Business (LinkedIn)
Higher education leader, teacher and researcher with a passion for creating project-based, experiential learning opportunities for students and executives. He is specifically interested in the cognitive and social psychology behind effective decision-making, change management, predictive analytics, and talent assessment and selection. Much of his research is conducted within the context of employment assessments and interviews.
Alex Keller, Ph.D., Pharmacology (LinkedIn)
Alex graduated in May 2019 with a PhD from UVA's Department of Pharmacology. During his time in BIMS, he studied blood vessel signaling pathways in Brant Isakson's lab and was active in the GBS professional committee. Alex joined Boston Consulting Group in July 2019 and is a member of the firm's Washington, DC office, where his project work has focused primarily on biopharma and retail.
Yijing Shi, Ph.D., Materials Science and Engineering (LinkedIn)
Graduated from UVA with Ph.D. in materials science and engineering major in 2015. Was the founding member and president of the Graduate Consulting Club at UVA. Worked as a consultant and then an engagement manager at McKinsey in both China and the US from 2015-2019. Worked as a strategy lead at VMware focusing on corporate strategy and development in the last two years. Currently working as the head of strategy and operation at a stealth mode tech startup.
Kelly Drews, Ph.D., Molecular and Cellular Basis of Disease (LinkedIn)
Kelly earned his Ph.D. from UVA's Experimental Pathology department in 2019 before joining Triangle Insights Group, a boutique strategy consulting firm focusing on biotech and life sciences. After 1-2 years in commercial strategy consulting Kelly moved to IQVIA, a global CRO, and began consulting on clinical trial strategy and go-to-market approaches for a variety of products in Real-World Evidence. Kelly recently accepted a role at InterVenn to help lead their business development efforts in the oncology diagnostic space.